Vertex Pharmaceuticals

public companies
Biotech

Frazier Life Sciences nets $1.1B in long-running biotech fund

Frazier Life Sciences (FLS) has stacked up another sizable biotech-focused capital commitment, netting more than $1.1 billion for its long-running public fund.
Will Maddox Sep 10, 2026 9:44am
Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o

Invivyd's chair adds CEO role ahead of readout—Chutes & Ladders

Sep 4, 2026 8:30am
failure crash no fail rocket cancelled end

Sionna’s cystic fibrosis flop a ‘significant’ boost for Vertex

Aug 10, 2026 9:38am
Vertex

Vertex’s latest autoimmune TCE play involves $28M to AbCellera

Jul 29, 2026 8:20am
Metallic arrows futuristic

Eli Lilly takes top spot on new biopharma productivity ranking

Jul 28, 2026 1:00pm
A chessboard with blocks that read MA
Favicon Fierce Pharma

Vertex to pay $10B for Crinetics in its largest-ever deal

Jul 7, 2026 8:08am